Panacea Life Sciences Holdings, Inc.
PLSH
$0.0539
$0.005912.29%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -7.67M | -8.02M | -7.51M | -8.05M | -8.15M |
| Total Depreciation and Amortization | 1.67M | 1.71M | 1.71M | 1.73M | 1.73M |
| Total Amortization of Deferred Charges | 0.00 | 38.30K | 229.10K | 537.40K | 842.30K |
| Total Other Non-Cash Items | 1.53M | 1.71M | 1.11M | 1.92M | 1.62M |
| Change in Net Operating Assets | 2.90M | 3.03M | 2.41M | 1.84M | 1.68M |
| Cash from Operations | -1.57M | -1.52M | -2.05M | -2.03M | -2.28M |
| Capital Expenditure | -55.10K | -65.30K | -146.20K | -250.80K | -249.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 0.00 | 0.00 | 46.80K |
| Cash from Investing | -55.10K | -65.30K | -146.20K | -250.80K | -202.40K |
| Total Debt Issued | 1.94M | 2.09M | 3.58M | 3.73M | 4.23M |
| Total Debt Repaid | -286.90K | -407.10K | -1.42M | -1.47M | -1.73M |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.66M | 1.68M | 2.16M | 2.25M | 2.50M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 34.40K | 94.00K | -35.20K | -28.20K | 17.30K |
